Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JZJ Chain DrugstoreSHSE:605266 -1.38%78 Days Payable is 142.58 as of Mar. 2026, which is 17% below its 10-year median of 172.25. GuruFocus rates SHSE:605266 with a GF Score™ of 78/100 and a GF Value™ of ¥23.52 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 605 Healthcare Providers & Services companies, JZJ Chain Drugstore ranks better than 78.35% on this metric.
The historical rank and industry rank for JZJ Chain Drugstore's Days Payable or its related term are showing as below:
SHSE:605266'
s Days Payable Range Over the Past 10 Years
Min: 141.23 Med: 172.25 Max: 214.1
Current: 141.23
During the past 12 years, JZJ Chain Drugstore's highest Days Payable was 214.10. The lowest was 141.23. And the median was 172.25.
SHSE:605266's Days Payable is ranked better than 78.35% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.08
vs SHSE:605266: 141.23
JZJ Chain Drugstore's Days Payable
declined
from Mar. 2025 (156.21) to Mar. 2026 (142.58).
It may suggest that JZJ Chain Drugstoreaccelerated paying its suppliers.
JZJ Chain Drugstore Days Payable Related Terms
JZJ Chain Drugstore Days Payable Historical Data
* Premium members only.
The historical data trend for JZJ Chain Drugstore's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JZJ Chain Drugstore Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, JZJ Chain Drugstore's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JZJ Chain Drugstore Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JZJ Chain Drugstore's Days Payable distribution charts can be found below:
* The bar in red indicates where JZJ Chain Drugstore's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
JZJ Chain Drugstore's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JZJ Chain Drugstore (SHSE:605266) has a Days Payable of 142.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JZJ Chain Drugstore and its competitors. This is 17% below median its historical median of 172.25. Over the past decade, JZJ Chain Drugstore's Days Payable has ranged from 141.23 to 214.10. According to the industry distribution chart, JZJ Chain Drugstore ranks #131 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 21.7%.
Is JZJ Chain Drugstore's Days Payable too high?
JZJ Chain Drugstore's current Days Payable of 142.58 is 17% below median its 10-year median of 172.25. Over the past 10 years, this metric has ranged from a low of 141.23 to a high of 214.10. The Healthcare Providers & Services industry median Days Payable is 57.08. JZJ Chain Drugstore's value of 142.58 is 149.8% above this industry median. Based on the distribution chart, JZJ Chain Drugstore ranks #131 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JZJ Chain Drugstore has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JZJ Chain Drugstore's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JZJ Chain Drugstore ranks #131 out of 605 companies for Days Payable. This places JZJ Chain Drugstore in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.08. JZJ Chain Drugstore's value of 142.58 is 149.8% above this benchmark. Historically, JZJ Chain Drugstore's own Days Payable has ranged from 141.23 to 214.10 over the past decade. While the company's 10-year median is 172.25 vs. the industry median of 57.08, JZJ Chain Drugstore has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.08, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JZJ Chain Drugstore's current Days Payable of 142.58 is 149.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JZJ Chain Drugstore and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JZJ Chain Drugstore's current Days Payable is 142.58, which is 17% below median its own 10-year median of 172.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JZJ Chain Drugstore stock overvalued right now?
Based on GuruFocus' analysis, JZJ Chain Drugstore (SHSE:605266) is currently considered Possible Value Trap. The stock's GF Value™ is ¥23.52, compared to a current price of ¥15.68 — trading 33.3% below its estimated fair value. The current Days Payable is 142.58, which is 17% below median its 10-year median of 172.25 and 149.8% above the Healthcare Providers & Services industry median of 57.08. JZJ Chain Drugstore's overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For JZJ Chain Drugstore (SHSE:605266), the current Days Payable is 142.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JZJ Chain Drugstore (SHSE:605266) Overvalued in 2026?
Based on GuruFocus' analysis, JZJ Chain Drugstore stock appears to be undervalued.
The current stock price of ¥15.68 is trading 33.3% below its estimated GF Value™ of ¥23.52.
GuruFocus considers JZJ Chain Drugstore to be Possible Value Trap.
Key valuation signals for SHSE:605266:
Days Payable: 142.58 (17% below median its 10-year median of 172.25)
GF Value™: ¥23.52 vs. price of ¥15.68 (33.3% below fair value)
Industry Position: 149.8% above the Healthcare Providers & Services median (#131 of 605)
No single metric tells the full story. See the SHSE:605266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JZJ Chain Drugstore Corp is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
78GF Score
Get the complete analysis for SHSE:605266
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605266 has been successfully added to your 
